Methods of determining therapies based on single cell characterization of circulating tumor cells (ctcs) in metastatic disease
CN108884494A
The unicellular Genome Atlas of circulating tumor cell is analyzed to characterize disease heterogeneity in metastatic disease
AU2016348401A1
Single cell genomic profiling of circulating tumor cells (CTCs) in metastatic disease to characterize disease heterogeneity
AU2016325617A1
Androgen receptor variant 7 as a biomarker for treatment selection in patients with metastatic castration resistant prostate cancer (mCRPC)
US2018155794A1
Intra-patient genomic heterogeneity of single circulating tumor cells (ctcs) associated to phenotypic ctc heterogeneity in metastatic castrate resistant prostate cancer (mcrpc)
EP3207377A1
Circulating tumor cell diagnostics for therapy targeting pd-l1
CN107250796A
For differentiating the circulating tumor cell diagnosis to the repellence of androgen receptor targeted therapies
US2017010268A1
Methods for analyzing rare circulating cells
US2015212089A1
Circulating tumor cell diagnostics for biomarkers predictive of resistance to androgen receptor (ar) targeted therapies
WO2015116780A1
Methods for the detection and quantification of circulating tumor cell mimics
US2016011198A1
Detection of prostate specific membrane antigen (psma) expression on circulating tumor cells (ctc)
EP3100047A1
Circulating tumor cell diagnostics for prostate cancer biomarkers
US2016040245A1
Circulating tumor cell diagnostics for detection of neuroendocrine prostate cancer (nepc)
WO2013049670A1
Method for optimizing the collection of rare cells in blood
WO2012103025A2
Methods for obtaining single cells and applications of single cell omics
